A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Apr 15, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the API SEC filings page.
Agora, Inc. American (API) reported $141.1M in revenue for fiscal year 2025, up 5.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Agora’s 2025 turnaround was driven primarily by operating-cost compression and cash conversion, while demand remained broadly restrained.
Revenue was only modestly higher, yet operating margin moved from-40.0% to-6.7% , pointing to expense reduction and better fixed-cost absorption rather than volume alone. Net income of$9.5M arrived alongside operating cash flow of$27.2M , showing that the earnings turnaround was accompanied by cash generation rather than just reported profit.
Gross margin expansion from
The balance sheet remains lightly leveraged relative to equity, but debt financing increased: long-term debt reached
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Agora, Inc. American's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Agora, Inc. American held $109.2M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $27.2M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Agora, Inc. American scores 85/100 among other emerging companies.
Agora, Inc. American had 349M shares outstanding at the end of fiscal year 2025, against 373M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Agora, Inc. American scores 77/100 among other emerging companies.
Agora, Inc. American spent $55.5M on research and development in fiscal year 2025, which was 36.9% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Agora, Inc. American scores 68/100 among other emerging companies.
Agora, Inc. American reported revenue of $141.1M in fiscal year 2025, against $133.3M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Agora, Inc. American scores 43/100 among other emerging companies.
Agora, Inc. American's operations generated $27.2M of cash in fiscal year 2025, against $14.1M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Agora, Inc. American scores 97/100 among other emerging companies.
Agora, Inc. American's cash, cash equivalents and investments came to $109.2M at the end of fiscal year 2025, against $158.3M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Agora, Inc. American scores 50/100 among other emerging companies.
Agora, Inc. American scores 0.87, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($343.3M) relative to total liabilities ($158.3M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Agora, Inc. American passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Agora, Inc. American generates $2.86 in operating cash flow ($27.2M OCF vs $9.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Agora, Inc. American reported an operating loss of $9.4M against $36K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Agora, Inc. American held $75.4M in cash against $80.4M in long-term debt as of Q4 2025.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
API Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
API Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q4'2420-F | Q4'2310-K | Q4'2210-K | Q4'2110-K | Q4'2010-K | Q4'1910-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $721.1M+3.1% | $699.7M+3.7% | $674.6M-15.8% | $800.7M-15.3% | $945.0M+36.4% | $692.9M+428.3% | $131.2M |
| Current Assets | $260.1M-20.7% | $328.1M+25.5% | $261.4M-46.2% | $485.5M-39.1% | $797.7M+18.9% | $670.7M+444.3% | $123.2M |
| Cash & Equivalents | $75.4M+178.6% | $27.1M-26.6% | $36.9M-19.2% | $45.7M-84.0% | $285.7M+156.9% | $111.2M+5.3% | $105.6M |
| Short-Term Investments | $4.6M+64.4% | $2.8M-65.1% | $8.0M-43.6% | $14.1M-97.0% | $469.6M-10.4% | $524.2M | $0 |
| Accounts Receivable | $24.9M-19.7% | $31.0M-10.7% | $34.7M+5.7% | $32.8M+0.6% | $32.6M+17.2% | $27.8M+71.3% | $16.2M |
| Long-Term Investments | $29.2M-28.3% | $40.7M-7.3% | $43.9M-20.4% | $55.2M+2.3% | $53.9M | $0 | $0 |
| Goodwill | N/A | N/A | $0-100.0% | $31.9M-43.1% | $56.1M+1717.5% | $3.1M | $0 |
| Total Liabilities | $158.3M+24.6% | $127.0M+81.8% | $69.8M-3.6% | $72.5M-8.0% | $78.7M+116.1% | $36.4M-85.9% | $258.5M |
| Current Liabilities | $56.8M-2.7% | $58.3M+2.5% | $56.9M-20.6% | $71.7M-2.9% | $73.8M+103.3% | $36.3M+96.5% | $18.5M |
| Non-Current Liabilities | $101.5M+47.8% | $68.7M+430.1% | $13.0M+1515.0% | $802K-83.7% | $4.9M+3582.8% | $134K | $0 |
| Long-Term Debt | $80.4M+73.1% | $46.5M+321.4% | $11.0M | $0 | N/A | N/A | N/A |
| Total Equity | $562.8M-1.7% | $572.7M-5.3% | $604.7M-17.0% | $728.3M-15.9% | $866.3M+32.0% | $656.5M+615.7% | -$127.3M |
| Retained Earnings | -$477.1M+2.0% | -$486.6M-9.6% | -$443.9M-24.5% | -$356.7M-50.9% | -$236.3M-44.1% | -$163.9M-29.8% | -$126.3M |
Not reported in any period shown, so not listed: Inventory.
API Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Share Buybacks.
API Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Agora, Inc. American API | FY2025 | $141.1M | $9.5M | 6.8% | $343.3M | 70/100 |
| Ooma Inc OOMA | FY2026 | $273.6M | $6.5M | 2.4% | $630.4M | 35/100 |
| Blaize Holdings BZAI | FY2025 | $38.6M | -$206.9M | N/A | $71.2M | 37/100 |
| Pubmatic, Inc. PUBM | FY2025 | $282.9M | -$14.0M | -5.0% | $737.0M | 43/100 |
| Cs Disco Inc LAW | FY2025 | $156.8M | -$44.4M | -28.3% | $263.6M | 66/100 |
| ReposiTrak TRAK | FY2025 | $22.6M | $7.0M | 30.9% | $143.0M | 88/100 |
Where Agora, Inc. American Ranks
Frequently Asked Questions
What is Agora, Inc. American's annual revenue?
Agora, Inc. American (API) reported $141.1M in total revenue for fiscal year 2025. This represents a 5.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Agora, Inc. American's revenue growing?
Agora, Inc. American (API) revenue grew by 5.9% year-over-year, from $133.3M to $141.1M in fiscal year 2025.
Is Agora, Inc. American profitable?
Yes, Agora, Inc. American (API) reported a net income of $9.5M in fiscal year 2025, with a net profit margin of 6.8%.
What is Agora, Inc. American's EBITDA?
Agora, Inc. American (API) had EBITDA of -$7.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Agora, Inc. American have?
As of fiscal year 2025, Agora, Inc. American (API) had $75.4M in cash and equivalents against $80.4M in long-term debt.
What is Agora, Inc. American's gross margin?
Agora, Inc. American (API) had a gross margin of 66.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Agora, Inc. American's operating margin?
Agora, Inc. American (API) had an operating margin of -6.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Agora, Inc. American's net profit margin?
Agora, Inc. American (API) had a net profit margin of 6.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Agora, Inc. American's return on equity (ROE)?
Agora, Inc. American (API) has a return on equity of 1.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Agora, Inc. American's free cash flow?
Agora, Inc. American (API) generated $25.5M in free cash flow during fiscal year 2025. This represents a 253.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Agora, Inc. American's operating cash flow?
Agora, Inc. American (API) generated $27.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Agora, Inc. American's total assets?
Agora, Inc. American (API) had $721.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Agora, Inc. American's capital expenditures?
Agora, Inc. American (API) invested $1.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Agora, Inc. American spend on research and development?
Agora, Inc. American (API) invested $55.5M in research and development during fiscal year 2025.
What is Agora, Inc. American's current ratio?
Agora, Inc. American (API) had a current ratio of 4.58 as of fiscal year 2025, which is generally considered healthy.
What is Agora, Inc. American's debt-to-equity ratio?
Agora, Inc. American (API) had a debt-to-equity ratio of 0.14 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Agora, Inc. American's return on assets (ROA)?
Agora, Inc. American (API) had a return on assets of 1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Agora, Inc. American's P/E ratio?
Agora, Inc. American (API) trades at 36.0x earnings, its market capitalization divided by net income of $9.5M net income, FY2025. The market capitalization is $343.3M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Agora, Inc. American's price-to-sales ratio?
Agora, Inc. American (API) trades at 2.4x sales, its market capitalization divided by revenue of $141.1M revenue, FY2025. The market capitalization is $343.3M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Agora, Inc. American's Altman Z-Score?
Agora, Inc. American (API) has an Altman Z-Score of 0.87, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Agora, Inc. American's Piotroski F-Score?
Agora, Inc. American (API) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Agora, Inc. American's earnings high quality?
Agora, Inc. American (API) has an earnings quality ratio of 2.86x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Agora, Inc. American cover its interest payments?
Agora, Inc. American (API) reported an operating loss of $9.4M against $36K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Agora, Inc. American?
Agora, Inc. American (API) scores 70 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.